Browse our collection of papers in
GlaxoSmithKline (GSK)
C/HR/744. Dissertation. Communication challenges arising from off shoring to India. GSK case study.
- WORDS:
- 13400
- DATE:
- 2010
- PRICE:
- 139.99 GBP
This dissertation looks at the off shoring of US and UK firms to India for selected activities, in particular IT outsourcing. The dissertation is focused on a case study of GlaxoSmithKline (GSK) and the company’s initiative of offshoring part of their activities. The dissertation outlines how offshoring provides a number of benefits to firms such as lowering the cost of services as well as concentrating the skills and capabilities of specific functions in one area, and these benefits are expected to ensure that firms will continue to pursue offshoring as part of their overall strategy. The dissertation addresses the following issues: Understand the communications and training challenges that US and UK firms faced in their transactions with Indian IT vendor personnel, Assess the communications between the US and UK personnel with their India counterparts, and provide recommendations to address the challenges identified in the communications and training related to off shoring of functions. A literature review is followed by the use of conversation analysis (ca) to analyse cross-cultural communications.
KEYWORDS: Dissertation, Offshoring, India, GSK, GlaxoSmithKline communication challenges, IT outsourcing, conversation analysis, CA, HRO, human resource outsourcing, international business, international culture, cross cultural,
C/M/1543. Disaster and security management: theory and case studies
- WORDS:
- 3550
- DATE:
- 2010
- PRICE:
- 39.99 GBP
The paper looks at the practices of disaster and security management (DSM) examining case studies related to different areas of DSM: the failure of intelligence in business continuity at British Petroleum (BP), the problem of crisis communications in the management of the disaster at Trans World Airlines (TWA) Flight 800, and the incident involving a contaminated toothpaste product in GlaxoSmithKline (GSK).
KEYWORDS: Disaster and security management, British Petroleum, crisis communications, Trans World Airlines, GlaxoSmithKline,
C/B/2265. Strategic directions of pharmaceutical companies GSK, Pfizer and Novartis
- WORDS:
- 1250
- DATE:
- 2010
- PRICE:
- 19.99 GBP
The paper examines the strategic development of companies operating in the pharmaceutical industry, i.e. GlaxoSmithKline (GSK), Pfizer and Novartis. Key competences, capabilities and resources of GSK are discussed with references to the theory of strategy.
KEYWORDS: GlaxoSmithKline, GSK, Pfizer, Novartis, pharmaceutical industry, strategic directions,
C/OM/207. Quality management in Shoeshine PLC
- WORDS:
- 1850
- DATE:
- 2010
- PRICE:
- 19.99 GBP
The paper looks at the strategic objectives of operations management (OM) using the examples of GlaxoSmithKline (GSK) and Sainsbury’s, and conducting a case study of OM in Shoeshine PLC. The company’s strategic and organisational objectives are examined suggesting recommendations about the ways to improve organisational performance through cost, time and quality.
KEYWORDS: Shoeshine, Sainsbury’s, GlaxoSmithKline, GSK, Operations Management,
C/OM/197. Innovation Audit: Use of Molecular Clinical Safety Intelligence System by GlaxoSmithKline
- WORDS:
- 1400
- DATE:
- 2010
- PRICE:
- 19.99 GBP
The paper looks at the Molecular Clinical Safety Intelligence (MCSI), a unique intelligent knowledge management system used by GlaxoSmithKline (GSK) to screen potential candidates and identify possible health issues prior to clinical development. Organisational context of GSK is described, their investment in innovative technologies is discussed, the importance of MCSI system for the development of new drugs is highlighted.
KEYWORDS: Molecular Clinical Safety Intelligence, MCSI, Innovation, GlaxoSmithKline, GSK, Pharmaceutical, new drugs development,
C/B/2111. Corporate social responsibility in pharmaceutical industry: case study of GlaxoSmithKline
- WORDS:
- 1000
- DATE:
- 2010
- PRICE:
- 19.99 GBP
The paper describes the environment of the pharmaceutical industry highlighting its challenges and threats, addressing the issues of corporate social responsibility (CSR) faced by pharmaceutical companies, and examining the mission of GlaxoSmithKline (GSK) with regard to their CSR implementation.
KEYWORDS: pharmaceutical industry, GlaxoSmithKline, GSK, corporate social responsibility, CSR,
C/B/2096. UK healthcare system and strategic issues faced by GlaxoSmithKline
- WORDS:
- 4000
- DATE:
- 2010
- PRICE:
- 49.99 GBP
The paper looks at the challenges facing the companies that operate within the UK healthcare system presenting a case study of the pharmaceutical company GlaxoSmithKline (GSK). The business environment of the UK healthcare system and national health service (NHS) is analysed, SWOT analysis of GSK is conducted, scenarios for the company development are considered, the role of leadership and governance in GSK change management is evaluated.
KEYWORDS: GSK, GlaxoSmithKline, UK Healthcare, National Health Services, NHS, Pharmaceutical,
C/N/297. GlaxoSmithKline (GSK) and Production of Swine Flu Vaccines
- WORDS:
- 2800
- DATE:
- 2009
- PRICE:
- 29.99 GBP
The paper addresses the issue of combating the global flu epidemic of Swine flu (H1N1) using a case study of the GSK vaccine unit. Analysis is conducted of the production of regular and swine flu vaccines using the PESTEL model, pharmaceutical industry life cycle analysis, Porter’s Five Forces and SWOT analysis of the GSK vaccine unit, analysis of the unique resources of the GSK vaccine unit, etc. The risk of dividing production between regular vaccine and swine flu vaccine is discussed suggesting the production of both regular and swine flu vaccines by GSK’s vaccine unit.
KEYWORDS: GlaxoSmithKline, GSK, Swine Flu Vaccines, SWOT, Porter’s five forces, PESTEL, Value Chain,
C/F/560. Strategic Financial Analysis of AstraZeneca and GlaxoSmithKline
- WORDS:
- 3100
- DATE:
- 2009
- PRICE:
- 39.99 GBP
The paper examines the factors that affected the financial performance of AstraZeneca (AZN) and GlaxoSmithKline (GSK) giving particular focus to the analysis of the product portfolio and recent developments in the pharmaceutical industry. An overview of the companies’ ratios over 2004-2008 is provided suggesting recommendations for the investors.
KEYWORDS: GlaxoSmithKline, GSK, AstraZeneca, AZN, pharmaceutical industry,
S/B/510. Dissertation. Impact of newspaper publicity on social and environmental disclosures in annual reports
- WORDS:
- 13800
- DATE:
- 2009
- PRICE:
- 139.99 GBP
The dissertation explores the outcomes of negative publicity received through newspaper articles on companies' disclosure levels. Literature is reviewed on the role of the media in shaping society attitudes reporting on the MNC exposed by the media, i.e. Cadbury Schweppes, GlaxoSmithKline, Royal Dutch Shell and Tesco. Content analysis is used as a preferred research methods, the relevance of newspaper articles for companies' exposure is studied. Conclusions are made about companies' responses to positive and negative media publicity.
KEYWORDS: Dissertation, disclosure, negative publicity, legitimacy, annual report, climate change,
C/F/416. Financial Performance Analysis: GSK vs. Johnson and Johnson
- WORDS:
- 2600
- DATE:
- 2009
- PRICE:
- 29.99 GBP
This report looks at Financial Structure of two pharmaceutical companies i.e. GlaxoSmithKline and Johnson & Johnson. It examines the fiscal fitness of the company with the help of different financial ratios for 2003-2007 years. For each company five year financial data has been analyzed to check the overall performance of the company. Moving forward to check the corporate responsibility, share performance of the company has been diagnosed by way of dividend and earnings per share. Finally, financial performance of both the companies is compared to each other.
KEYWORDS: f, financial, performance, analysis, gsk, vs, johnson, johnson,
C/B/1158. Dissertation. Management Analysis of GlaxoSmithKline
- WORDS:
- 10600
- DATE:
- 2008
- PRICE:
- 109.99 GBP
The dissertation addresses the issues of strategic management in the world leading pharmaceutical company GlaxoSmithKline (GSK). Customer, industry and competitor analysis of the pharmaceutical industry is presented, the background of GSK is described, their core values, resources, competences and strategic competitiveness are defined conducting SWOT, Porter's Generic Strategies and value chain analysis. Growth strategies related to their market and product development are identified and evaluated. Recommendations are suggested about the strategies towards the existing and new markets and products.
KEYWORDS: dissertation, management, glaxosmithkline,
C/B/852. Dissertation. Do Mergers and Acquisition Always Bring the Desired Effects?
- WORDS:
- 10000
- DATE:
- 2008
- PRICE:
- 109.99 GBP
The main aim of this dissertation is to understand the dynamics of major variables that impact on the success of merger and acquisition across industries from a corporate strategic perspective. The aim has further been divided into specific objectives that include: to understand the dynamics of major variables that impact on the success of merger and acquisition across industries from a corporate strategic perspective, to highlight the corporate strategy in achieving desired results from M&A activities, and in the light of the analysis, develop strategic recommendations for companies that are considering M&A strategy to achieve desired effects. The dissertation includes the following chapters: introduction, literature review, methodology, analysis and findings, and conclusions and recommendations. This dissertation analyses the following mergers: Hewlett-Packard and Apollo, British Petroleum and Amoco, NatWest and Royal Bank of Scotland, Glaxo Wellcome and SmithKline Beecham, Halifax and Bank of Scotland, Banco Santander and Abbey and Boots and Alliance Unichem.
KEYWORDS: Mergers, Acquisitions, M&A, Strategic Management, Proposal, Dissertation,
C/B/853. Dissertation + Proposal. Do Mergers and Acquisition Always Bring the Desired Effects?
- WORDS:
- 10000
- DATE:
- 2008
- PRICE:
- 119.99 GBP
The main aim of this dissertation is to understand the dynamics of major variables that impact on the success of merger and acquisition across industries from a corporate strategic perspective. The aim has further been divided into specific objectives that include: to understand the dynamics of major variables that impact on the success of merger and acquisition across industries from a corporate strategic perspective, to highlight the corporate strategy in achieving desired results from M&A activities, and in the light of the analysis develop strategic recommendations for companies that are considering M&A strategy to achieve desired effects The dissertation includes the following chapters: introduction, literature review, methodology, analysis and findings, and conclusions and recommendations. This dissertation analyses the following mergers: Hewlett-Packard and Apollo, British Petroleum and Amoco, NatWest and Royal Bank of Scotland, Glaxo Wellcome and SmithKline Beecham, Halifax and Bank of Scotland, Banco Santander and Abbey and Boots and Alliance Unichem. Proposal for this dissertation is provided in the appendix.
KEYWORDS: Dissertation, Merger, Acquisitions, M&A, Value Addition, Strategic Management,
C/B/854. Proposal: Do Mergers and Acquisition Always Bring the Desired Effects?
- WORDS:
- 1500
- DATE:
- 2008
- PRICE:
- 19.99 GBP
The main aim of this proposed project is to understand the dynamics of major variables that impact on the success of merger and acquisition across industries from a corporate strategic perspective. The report includes sections such as introduction, aims and objectives, initial literature review, and methodology based on case studies and secondary data collection. Case studies analysed are: Hewlett-Packard and Apollo, British Petroleum and Amoco, NatWest and Royal Bank of Scotland, Glaxo Wellcome and SmithKline Beecham, Halifax and Bank of Scotland, Banco Santander and Abbey and Boots and Alliance Unichem.
KEYWORDS: Dissertation, Merger, Acquisitions, M&A, Value Addition, Strategic Management,
C/F/278. AstraZeneca and GlaxoSmithKline share price performance valuation
- WORDS:
- 1300
- DATE:
- 2008
- PRICE:
- 19.99 GBP
The paper examines the factors that affected the share prices of AstraZeneca and GlaxoSmithKline, placing particular focus on the Company announcement published in the London Stock Exchange. A short overview of the company ratios is given suggesting recommendations for investors.
KEYWORDS: GlaxoSmithKline, AstraZeneca, pharmaceuticals,
S/F/173. Dissertation. Stock Market Prediction Using Technical Analysis: Case against Market Model
- WORDS:
- 19800
- DATE:
- 2008
- PRICE:
- 199.99 GBP
The dissertation investigates the effectiveness of technical analysis in the examination of equity prices in a bid for predicting future the price movements of the equity. Literature is reviewed on the theory of the efficient market, the features and tools of technical (descriptive and statistical) analysis, the issues of stock market volatility, etc. The methods of research are described detailing the philosophy and strategy of the study based on GlaxoSmithKline (GSK) and British Petroleum (BP), and describing the techniques of primary data collection, i.e. questionnaires and interviews. Research findings are analyzed with respect to GSK and BP. Conclusions are made about the accuracy of technical analysis in predicting stock price movements and the usefulness of the relative strength index (RSI).
KEYWORDS: Dissertation, equity prices, stock market, efficient market, volatility, relative stre,
C/B/575. Equilibrium between Control & Entrepreneurship: the Case of GlaxoSmithKline
- WORDS:
- 1300
- DATE:
- 2007
- PRICE:
- 19.99 GBP
This report has been aimed at exploring ways to find equilibrium between control and entrepreneurship, two diametrically opposite concepts having their own advantages for organizations. The case of GlaxoSmithKline has been used for the purpose of this discussion. GSK is among the top 20 FT Global 500 companies and among the top 5 pharmaceutical companies in the world. GSK develops, manufactures and markets pharmaceuticals, vaccines, over-the-counter medicines and health-related consumer products.
KEYWORDS: GlaxoSmithKline, GSK, Strategy Implementation, Entrepreneurship, Control,
C/F/176. Risk Management: GlaxoSmithKline
- WORDS:
- 3000
- DATE:
- 2007
- PRICE:
- 39.99 GBP
This report has been aimed at discussing the impact of using effective risk management strategy in an organizational perspective. In order to achieve this aim, researcher has chosen the research and development (R&D) department of one of the top research-based pharmaceutical companies, GlaxoSmithKline (GSK). The analysis has been divided into two distinct parts where the first part identifies the key sources of uncertainty about performance of R&D department, and the management of these uncertainty sources by GSK and their effectiveness.
KEYWORDS: GSK, GlaxoSmithKline, Risk Management, R&D, Pharmaceuticals, Slack,
C/L/173. Intellectual Property Negotiation: GSK vs. Harbin
- WORDS:
- 3300
- DATE:
- 2007
- PRICE:
- 39.99 GBP
This report has been produced to analyse the negotiations regarding the intellectual property rights agreement between GlaxoSmithKline, one of the leading research based pharmaceutical company and Harbin Pharmaceutical Group Holding Co. Ltd., a state holding Sino Foreign Joint Venture for the drug Cervarix TM, which is vaccine against human papillomavirus (HPV) that causes cervical cancer. The negotiations ended with GSK signing a 15 year contract with Harbin and approved for distribution in Australia in May 2007 for women aged 10 to 45
KEYWORDS: GSK, Harbin, China, Negotiation, IP, Intellectual Property, Pharmaceutical Industry,
C/M/439. Critique on Soft Systems Methodology: GlaxoSmithKline
- WORDS:
- 6000
- DATE:
- 2007
- PRICE:
- 69.99 GBP
The aim of this essay is to analyze the appropriateness of the use of Soft System Methodology (SSM) for research based pharmaceuticals in the domain of strategic management. GlaxoSmithKline has been chosen as a case study to understand the dynamics of implications of Soft Systems Thinking (SST) within research-based pharmaceuticals. An in-depth analysis of the company based on Soft System Methodology (SSM) has been presented. The essay uses theoretical backing to argue the appropriateness of soft systems thinking for strategic management. On the other hand, it consolidates the analysis using 'rich diagrams', root definition and conceptual diagrams.
KEYWORDS: Soft Systems Methodology, SSM, System Theory, GSK, GlaxoSmithKline, Strategic Manageme,
C/M/591. Glaxo Wellcome & SmithKline Beecham Merger: Change Management
- WORDS:
- 3500
- DATE:
- 2007
- PRICE:
- 39.99 GBP
The paper examines the merger of Glaxo Wellcome & SmithKline Beecham, one of the most pronounced within the pharmaceutical industry in the light of change management theories. The research focuses on four major characteristics i.e. cultural theory, leadership theory, facilitating change, and communicating strategy during a change situation.
KEYWORDS: GSK, Merger, Acquisition, Pharmaceutical, Glaxo, Change Management,
C/M/636. Glaxo Wellcome & SmithKline Beecham Merger: Change Management
- WORDS:
- 3600
- DATE:
- 2007
- PRICE:
- 39.99 GBP
The paper examines the merger of Glaxo Wellcome & SmithKline Beecham, one of the most pronounced within the pharmaceutical industry, in the light of change management theories. The research touches on the cultural theory, leadership theory, change facilitation theory and the techniques of communicating during a change situation.
KEYWORDS: GSK, Merger, Acquisition, Pharmaceutical, Glaxo, Change Management,
C/OM/54. Operations Management: Speeding the Process at GlaxoSmithKline
- WORDS:
- 5000
- DATE:
- 2007
- PRICE:
- 59.99 GBP
This report has been aimed at understanding the operations that are aimed to improve the speed of research and development (R&D) activities that is a source of sustainable competitive advantage for pharmaceutical industry. The report has been divided into three parts i.e. a) Maps the process out, identifying timings for steps using an appropriate scale and identifies the objectives the process owners had for speeding up the process. b) Investigates whether the attempts to speed up the process have worked, and where perhaps it has not. c) Use of reading and experience to help critically review the attempt to speed the process, considering the limitations of the project and suggesting how company would improve it for the future.
KEYWORDS: R&D, Operations Management, Speed, Re-engineering, GSK, Pharmaceutical, Change Managem,
C/B/467. GSK: PESTEL Analysis
- WORDS:
- 630
- DATE:
- 2006
- PRICE:
- 9.99 GBP
Business organisations are entities with many interrelated parts, which can be affected by a variety of factors, namely political, economic, social, technological, legal and ethical. The paper conducts a PESTLE analysis on a GSK and pharmaceutical industry and explains how the analysis might be useful for the firm or the industry's future planning.
KEYWORDS: GSK, PESTEL, pharmaceutical Industry,
Subject Catalogue
- Dissertations and Proposals
- Analysis of Companies
- Analysis of Industries
- Architecture, Design and Technology
- Computing and Mathematics
- E-Commerce and E-Business
- Economics
- Education
- Engineering
- Fashion and Culture
- Finance and Accounting
- General Business
- History
- Hospitality and Tourism
- Human Resource Management
- International Relations
- Law
- Literature, Language and Theatre Studies
- Management and Organisational Behaviour
- Marketing
- Media, Music and Art
- Operations Management
- Philosophy
- Politics
- Psychology
- Science, Medicine and Nursing
- Sociology
GET OUR GooGLE TOOLBAR BUTTON
BOOK MARK US
WHAT OTHERS HAVE SAID
As a new customer I can now trust your services.Erin
